Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Cymabay Therapeutics (CBAY)

5.13 +0.02 (+0.39%)

6/22/2017  4:00pm

Open:

5.12

Pre. Close:

5.11

High:

5.44

Low:

5.10

Volume:

434,913

Market Cap:

147.50M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.6 - 5.76

5.76 - 5.88

Low:

4.7 - 4.87

4.87 - 5.02

Close:

4.97 - 5.2

5.2 - 5.38

Technical analysis  (as of: 2017-06-22 4:36:23 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 6.35     One year: 7.42

Support:

Support1: 4.35    Support2: 3.67

Resistance:

Resistance1: 5.44    Resistance2: 6.35

Pivot:

4.81

Moving Averages:

MA(5): 5.07     MA(20): 4.67

MA(100): 3.71     MA(250): 2.61

MACD:

MACD(12,26): 0.29     Signal(12,26,9): 0.26

%K %D:

%K(14,3): 77.87     %D(3): 81.09

RSI:

RSI(14): 67.94

52-Week:

High: 5.44  Low: 1.15  Change(%): 198.3

Average Vol(K):

3-Month: 326  10-Days 442

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CBAY has closed below upper band by 13.2%. Bollinger Bands are 17.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 24 Mar 2017 01:18:45 GMT
CymaBay Therapeutics' (CBAY) CEO Hal Van Wart on Q4 2016 Results - Earnings ...

Thu, 22 Jun 2017 11:48:45 GMT
Cymabay Therapeutics, Inc. (NasdaqCM:CBAY): Stock Rundown & Valuation Review

Fri, 12 May 2017 00:00:00 GMT
CymaBay Therapeutics' (CBAY) CEO Sujal Shah on Q1 2017 Results - Earnings Call ...

Tue, 06 Dec 2016 13:00:57 GMT
CymaBay Therapeutics Announces that the Recommended International ...

Thu, 05 Jan 2017 13:02:47 GMT
CymaBay Therapeutics Announces Successful Completion of Scientific Advice ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

28.75

Shares Float (M)

24.94

% Held by Insiders

5.27

% Held by Institutions

30.00

Shares Short (K)

706

Shares Short Prior Month (K)

721

Stock Financials

EPS

-1.040

EPS Est. Current Year

-0.860

EPS Est. Next Year

-0.990

EPS Est. Next Quarter

-0.160

Forward EPS

-0.990

Book Value (p.s.)

0.320

PEG Ratio

Profit Margin

Operating Margin

-426.58

Return on Assets (ttm)

-41.1

Return on Equity (ttm)

-162.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.710

Qtrly Earnings Growth

Operating Cash Flow (M)

-19.42

Levered Free Cash Flow (M)

-7.36

FoxReading.com

Valuation

P/E

-4.93

P/E Growth Ratio

P/BV

16.03

P/S

737437504.00

P/CF

-7.59

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.